WORLDWIDE CLINICAL TRIALS has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan WORLDWIDE CLINICAL TRIALS 401(K) PLAN
Measure | Date | Value |
---|
2021 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2021 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
Total transfer of assets to this plan | 2021-12-31 | $0 |
Total transfer of assets from this plan | 2021-12-31 | $67,855,360 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $34,551 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $15,282,805 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $9,779,541 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $9,775,040 |
Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $-91,674 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $9,578,182 |
Value of total assets at end of year | 2021-12-31 | $34,551 |
Value of total assets at beginning of year | 2021-12-31 | $62,352,096 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $96,175 |
Total interest from all sources | 2021-12-31 | $31,671 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $450,014 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $450,014 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $5,226,664 |
Participant contributions at beginning of year | 2021-12-31 | $679,475 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $2,395,894 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2021-12-31 | $34,551 |
Other income not declared elsewhere | 2021-12-31 | $158,205 |
Administrative expenses (other) incurred | 2021-12-31 | $96,175 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $5,503,264 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $0 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $62,352,096 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $34,551 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $61,672,621 |
Interest on participant loans | 2021-12-31 | $31,671 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $5,064,733 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | Yes |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $1,955,624 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $9,775,040 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Disclaimer |
Accountancy firm name | 2021-12-31 | KREISCHER MILLER |
Accountancy firm EIN | 2021-12-31 | 231980475 |
2020 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2020 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total transfer of assets to this plan | 2020-12-31 | $0 |
Total transfer of assets from this plan | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $18,908,696 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $5,913,795 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $5,739,568 |
Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $74,221 |
Value of total corrective distributions | 2020-12-31 | $8,499 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $9,719,325 |
Value of total assets at end of year | 2020-12-31 | $62,352,096 |
Value of total assets at beginning of year | 2020-12-31 | $49,357,195 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $91,507 |
Total interest from all sources | 2020-12-31 | $28,180 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $1,948,598 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $1,948,598 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $4,984,249 |
Participant contributions at end of year | 2020-12-31 | $679,475 |
Participant contributions at beginning of year | 2020-12-31 | $511,450 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $2,802,016 |
Other income not declared elsewhere | 2020-12-31 | $103,717 |
Administrative expenses (other) incurred | 2020-12-31 | $91,507 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $12,994,901 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $62,352,096 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $49,357,195 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $61,672,621 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $48,845,745 |
Interest on participant loans | 2020-12-31 | $28,180 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $7,108,876 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | Yes |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $1,933,060 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $5,739,568 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | KREISCHER MILLER |
Accountancy firm EIN | 2020-12-31 | 231980475 |
2019 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2019 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total transfer of assets to this plan | 2019-12-31 | $0 |
Total transfer of assets to this plan | 2019-12-31 | $0 |
Total transfer of assets from this plan | 2019-12-31 | $0 |
Total transfer of assets from this plan | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total income from all sources (including contributions) | 2019-12-31 | $16,004,944 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total of all expenses incurred | 2019-12-31 | $2,658,048 |
Total of all expenses incurred | 2019-12-31 | $2,658,048 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $2,514,185 |
Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $61,090 |
Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $61,090 |
Value of total corrective distributions | 2019-12-31 | $7,350 |
Value of total corrective distributions | 2019-12-31 | $7,350 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $7,396,031 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $7,396,031 |
Value of total assets at end of year | 2019-12-31 | $49,357,195 |
Value of total assets at end of year | 2019-12-31 | $49,357,195 |
Value of total assets at beginning of year | 2019-12-31 | $36,010,299 |
Value of total assets at beginning of year | 2019-12-31 | $36,010,299 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $75,423 |
Total interest from all sources | 2019-12-31 | $30,560 |
Total interest from all sources | 2019-12-31 | $30,560 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $1,832,100 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $1,832,100 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $1,832,100 |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $1,832,100 |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $500,000 |
Value of fidelity bond cover | 2019-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2019-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $4,460,879 |
Contributions received from participants | 2019-12-31 | $4,460,879 |
Participant contributions at end of year | 2019-12-31 | $511,450 |
Participant contributions at end of year | 2019-12-31 | $511,450 |
Participant contributions at beginning of year | 2019-12-31 | $543,206 |
Participant contributions at beginning of year | 2019-12-31 | $543,206 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $1,033,047 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $1,033,047 |
Other income not declared elsewhere | 2019-12-31 | $83,901 |
Other income not declared elsewhere | 2019-12-31 | $83,901 |
Administrative expenses (other) incurred | 2019-12-31 | $75,423 |
Administrative expenses (other) incurred | 2019-12-31 | $75,423 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $13,346,896 |
Value of net income/loss | 2019-12-31 | $13,346,896 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $49,357,195 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $49,357,195 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $36,010,299 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $36,010,299 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $48,845,745 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $48,845,745 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $35,467,093 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $35,467,093 |
Interest on participant loans | 2019-12-31 | $30,560 |
Interest on participant loans | 2019-12-31 | $30,560 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $6,662,352 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $6,662,352 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $1,902,105 |
Contributions received in cash from employer | 2019-12-31 | $1,902,105 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $2,514,185 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $2,514,185 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | KREISCHER MILLER |
Accountancy firm EIN | 2019-12-31 | 231980475 |
Accountancy firm EIN | 2019-12-31 | 231980475 |
2018 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2018 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2018-12-31 | $0 |
Total transfer of assets to this plan | 2018-12-31 | $0 |
Total transfer of assets from this plan | 2018-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total income from all sources (including contributions) | 2018-12-31 | $4,024,985 |
Total loss/gain on sale of assets | 2018-12-31 | $0 |
Total of all expenses incurred | 2018-12-31 | $4,292,333 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $4,276,395 |
Expenses. Certain deemed distributions of participant loans | 2018-12-31 | $8,114 |
Value of total corrective distributions | 2018-12-31 | $172 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $6,563,273 |
Value of total assets at end of year | 2018-12-31 | $36,010,299 |
Value of total assets at beginning of year | 2018-12-31 | $36,277,647 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $7,652 |
Total interest from all sources | 2018-12-31 | $20,846 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $2,330,867 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $2,330,867 |
Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
Value of fidelity bond cover | 2018-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2018-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Contributions received from participants | 2018-12-31 | $4,187,066 |
Participant contributions at end of year | 2018-12-31 | $543,206 |
Participant contributions at beginning of year | 2018-12-31 | $432,421 |
Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $558,386 |
Other income not declared elsewhere | 2018-12-31 | $5,048 |
Administrative expenses (other) incurred | 2018-12-31 | $7,652 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $-267,348 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $36,010,299 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $36,277,647 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $35,467,093 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $35,845,226 |
Interest on participant loans | 2018-12-31 | $20,846 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-4,895,049 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Contributions received in cash from employer | 2018-12-31 | $1,817,821 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $4,276,395 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
Accountancy firm name | 2018-12-31 | KREISCHER MILLER |
Accountancy firm EIN | 2018-12-31 | 231980475 |
2017 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2017 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2017-12-31 | $0 |
Total transfer of assets to this plan | 2017-12-31 | $0 |
Total transfer of assets from this plan | 2017-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total income from all sources (including contributions) | 2017-12-31 | $10,336,710 |
Total loss/gain on sale of assets | 2017-12-31 | $0 |
Total of all expenses incurred | 2017-12-31 | $3,227,902 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $3,176,865 |
Expenses. Certain deemed distributions of participant loans | 2017-12-31 | $3,164 |
Value of total corrective distributions | 2017-12-31 | $29,077 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $5,402,741 |
Value of total assets at end of year | 2017-12-31 | $36,277,647 |
Value of total assets at beginning of year | 2017-12-31 | $29,168,839 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $18,796 |
Total interest from all sources | 2017-12-31 | $18,922 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $1,412,830 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $1,412,830 |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2017-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Contributions received from participants | 2017-12-31 | $3,740,542 |
Participant contributions at end of year | 2017-12-31 | $432,421 |
Participant contributions at beginning of year | 2017-12-31 | $487,414 |
Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $31,235 |
Other income not declared elsewhere | 2017-12-31 | $4,997 |
Administrative expenses (other) incurred | 2017-12-31 | $18,796 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $7,108,808 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $36,277,647 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $29,168,839 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $35,845,226 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $28,681,425 |
Interest on participant loans | 2017-12-31 | $18,922 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $3,497,220 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Contributions received in cash from employer | 2017-12-31 | $1,630,964 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $3,176,865 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
Accountancy firm name | 2017-12-31 | KREISCHER MILLER |
Accountancy firm EIN | 2017-12-31 | 231980475 |
2016 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2016 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2016-12-31 | $0 |
Total transfer of assets to this plan | 2016-12-31 | $0 |
Total transfer of assets from this plan | 2016-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total income from all sources (including contributions) | 2016-12-31 | $7,444,911 |
Total loss/gain on sale of assets | 2016-12-31 | $0 |
Total of all expenses incurred | 2016-12-31 | $7,098,111 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $7,015,591 |
Expenses. Certain deemed distributions of participant loans | 2016-12-31 | $3,438 |
Value of total corrective distributions | 2016-12-31 | $70,990 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $5,219,953 |
Value of total assets at end of year | 2016-12-31 | $29,168,839 |
Value of total assets at beginning of year | 2016-12-31 | $28,822,039 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $8,092 |
Total interest from all sources | 2016-12-31 | $17,446 |
Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $910,919 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $910,919 |
Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
Value of fidelity bond cover | 2016-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2016-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2016-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
Contributions received from participants | 2016-12-31 | $3,397,752 |
Participant contributions at end of year | 2016-12-31 | $487,414 |
Participant contributions at beginning of year | 2016-12-31 | $418,601 |
Income. Received or receivable in cash from other sources (including rollovers) | 2016-12-31 | $364,451 |
Other income not declared elsewhere | 2016-12-31 | $8,177 |
Administrative expenses (other) incurred | 2016-12-31 | $8,092 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Value of net income/loss | 2016-12-31 | $346,800 |
Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $29,168,839 |
Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $28,822,039 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $28,681,425 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $28,403,438 |
Interest on participant loans | 2016-12-31 | $17,446 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $1,288,416 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
Contributions received in cash from employer | 2016-12-31 | $1,457,750 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $7,015,591 |
Did the plan have assets held for investment | 2016-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Disclaimer |
Accountancy firm name | 2016-12-31 | MAXWELL LOCKE & RITTER LLP |
Accountancy firm EIN | 2016-12-31 | 742900215 |
2015 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2015 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2015-12-31 | $0 |
Total transfer of assets to this plan | 2015-12-31 | $0 |
Total transfer of assets from this plan | 2015-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total income from all sources (including contributions) | 2015-12-31 | $5,281,698 |
Total loss/gain on sale of assets | 2015-12-31 | $0 |
Total of all expenses incurred | 2015-12-31 | $3,167,951 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $3,053,066 |
Expenses. Certain deemed distributions of participant loans | 2015-12-31 | $5,655 |
Value of total corrective distributions | 2015-12-31 | $97,223 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $5,671,034 |
Value of total assets at end of year | 2015-12-31 | $28,822,039 |
Value of total assets at beginning of year | 2015-12-31 | $26,708,292 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $12,007 |
Total interest from all sources | 2015-12-31 | $15,343 |
Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $1,742,282 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2015-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2015-12-31 | $1,742,282 |
Was this plan covered by a fidelity bond | 2015-12-31 | Yes |
Value of fidelity bond cover | 2015-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2015-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2015-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
Contributions received from participants | 2015-12-31 | $2,997,160 |
Participant contributions at end of year | 2015-12-31 | $418,601 |
Participant contributions at beginning of year | 2015-12-31 | $357,421 |
Income. Received or receivable in cash from other sources (including rollovers) | 2015-12-31 | $1,296,991 |
Other income not declared elsewhere | 2015-12-31 | $7,671 |
Administrative expenses (other) incurred | 2015-12-31 | $12,007 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Value of net income/loss | 2015-12-31 | $2,113,747 |
Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $28,822,039 |
Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $26,708,292 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2015-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $28,403,438 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $26,350,871 |
Interest on participant loans | 2015-12-31 | $15,343 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-2,154,632 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2015-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2015-12-31 | No |
Contributions received in cash from employer | 2015-12-31 | $1,376,883 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2015-12-31 | $3,053,066 |
Did the plan have assets held for investment | 2015-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2015-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2015-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2015-12-31 | Disclaimer |
Accountancy firm name | 2015-12-31 | MAXWELL LOCKE & RITTER LLP |
Accountancy firm EIN | 2015-12-31 | 742900215 |
2014 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2014 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2014-12-31 | $0 |
Total transfer of assets to this plan | 2014-12-31 | $0 |
Total transfer of assets from this plan | 2014-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total income from all sources (including contributions) | 2014-12-31 | $5,808,367 |
Total loss/gain on sale of assets | 2014-12-31 | $0 |
Total of all expenses incurred | 2014-12-31 | $2,441,742 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $2,373,453 |
Expenses. Certain deemed distributions of participant loans | 2014-12-31 | $173 |
Value of total corrective distributions | 2014-12-31 | $55,795 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $4,622,895 |
Value of total assets at end of year | 2014-12-31 | $26,708,292 |
Value of total assets at beginning of year | 2014-12-31 | $23,341,667 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $12,321 |
Total interest from all sources | 2014-12-31 | $16,537 |
Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $1,762,469 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2014-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2014-12-31 | $1,762,469 |
Was this plan covered by a fidelity bond | 2014-12-31 | Yes |
Value of fidelity bond cover | 2014-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2014-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2014-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
Contributions received from participants | 2014-12-31 | $2,610,948 |
Participant contributions at end of year | 2014-12-31 | $357,421 |
Participant contributions at beginning of year | 2014-12-31 | $380,009 |
Income. Received or receivable in cash from other sources (including rollovers) | 2014-12-31 | $995,914 |
Other income not declared elsewhere | 2014-12-31 | $5,881 |
Administrative expenses (other) incurred | 2014-12-31 | $12,321 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Value of net income/loss | 2014-12-31 | $3,366,625 |
Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $26,708,292 |
Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $23,341,667 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2014-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2014-12-31 | $26,350,871 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2014-12-31 | $22,961,658 |
Interest on participant loans | 2014-12-31 | $16,537 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2014-12-31 | $-599,415 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2014-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2014-12-31 | No |
Contributions received in cash from employer | 2014-12-31 | $1,016,033 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2014-12-31 | $2,373,453 |
Did the plan have assets held for investment | 2014-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2014-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2014-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2014-12-31 | Disclaimer |
Accountancy firm name | 2014-12-31 | MAXWELL LOCKE & RITTER LLP |
Accountancy firm EIN | 2014-12-31 | 742900215 |
2013 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2013 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2013-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total income from all sources (including contributions) | 2013-12-31 | $6,938,885 |
Total loss/gain on sale of assets | 2013-12-31 | $0 |
Total of all expenses incurred | 2013-12-31 | $1,398,807 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $1,386,898 |
Expenses. Certain deemed distributions of participant loans | 2013-12-31 | $1,675 |
Value of total corrective distributions | 2013-12-31 | $309 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $3,673,422 |
Value of total assets at end of year | 2013-12-31 | $23,341,667 |
Value of total assets at beginning of year | 2013-12-31 | $17,801,589 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $9,925 |
Total interest from all sources | 2013-12-31 | $18,207 |
Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $1,133,137 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2013-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2013-12-31 | $1,133,137 |
Was this plan covered by a fidelity bond | 2013-12-31 | Yes |
Value of fidelity bond cover | 2013-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2013-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2013-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
Contributions received from participants | 2013-12-31 | $2,305,897 |
Participant contributions at end of year | 2013-12-31 | $380,009 |
Participant contributions at beginning of year | 2013-12-31 | $353,181 |
Income. Received or receivable in cash from other sources (including rollovers) | 2013-12-31 | $346,533 |
Other income not declared elsewhere | 2013-12-31 | $3,584 |
Administrative expenses (other) incurred | 2013-12-31 | $9,925 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Value of net income/loss | 2013-12-31 | $5,540,078 |
Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $23,341,667 |
Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $17,801,589 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2013-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2013-12-31 | $22,961,658 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2013-12-31 | $17,448,408 |
Interest on participant loans | 2013-12-31 | $18,207 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2013-12-31 | $2,110,535 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2013-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2013-12-31 | No |
Contributions received in cash from employer | 2013-12-31 | $1,020,992 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2013-12-31 | $1,386,898 |
Did the plan have assets held for investment | 2013-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2013-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2013-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2013-12-31 | Disclaimer |
Accountancy firm name | 2013-12-31 | MAXWELL LOCKE & RITTER LLP |
Accountancy firm EIN | 2013-12-31 | 742900215 |
2012 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2012 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2012-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total income from all sources (including contributions) | 2012-12-31 | $5,010,429 |
Total loss/gain on sale of assets | 2012-12-31 | $0 |
Total of all expenses incurred | 2012-12-31 | $2,425,456 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $2,341,009 |
Expenses. Certain deemed distributions of participant loans | 2012-12-31 | $4,264 |
Value of total corrective distributions | 2012-12-31 | $61,635 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $3,324,377 |
Value of total assets at end of year | 2012-12-31 | $17,801,589 |
Value of total assets at beginning of year | 2012-12-31 | $15,216,616 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-12-31 | $18,548 |
Total interest from all sources | 2012-12-31 | $17,783 |
Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $567,456 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2012-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2012-12-31 | $567,456 |
Was this plan covered by a fidelity bond | 2012-12-31 | Yes |
Value of fidelity bond cover | 2012-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2012-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2012-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2012-12-31 | No |
Contributions received from participants | 2012-12-31 | $2,193,078 |
Participant contributions at end of year | 2012-12-31 | $353,181 |
Participant contributions at beginning of year | 2012-12-31 | $343,316 |
Income. Received or receivable in cash from other sources (including rollovers) | 2012-12-31 | $136,930 |
Administrative expenses (other) incurred | 2012-12-31 | $18,548 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Value of net income/loss | 2012-12-31 | $2,584,973 |
Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $17,801,589 |
Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $15,216,616 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2012-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2012-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2012-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2012-12-31 | $17,448,408 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2012-12-31 | $14,873,300 |
Interest on participant loans | 2012-12-31 | $17,783 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2012-12-31 | $1,100,813 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2012-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2012-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2012-12-31 | No |
Contributions received in cash from employer | 2012-12-31 | $994,369 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2012-12-31 | $2,341,009 |
Did the plan have assets held for investment | 2012-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2012-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2012-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2012-12-31 | Disclaimer |
Accountancy firm name | 2012-12-31 | MAXWELL LOCKE & RITTER LLP |
Accountancy firm EIN | 2012-12-31 | 742900215 |
2011 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2011 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2011-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total income from all sources (including contributions) | 2011-12-31 | $2,116,662 |
Total loss/gain on sale of assets | 2011-12-31 | $0 |
Total of all expenses incurred | 2011-12-31 | $1,345,460 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $1,253,017 |
Expenses. Certain deemed distributions of participant loans | 2011-12-31 | $21,218 |
Value of total corrective distributions | 2011-12-31 | $55,316 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $2,696,334 |
Value of total assets at end of year | 2011-12-31 | $15,216,616 |
Value of total assets at beginning of year | 2011-12-31 | $14,445,414 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $15,909 |
Total interest from all sources | 2011-12-31 | $17,745 |
Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $375,389 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2011-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2011-12-31 | $375,389 |
Was this plan covered by a fidelity bond | 2011-12-31 | Yes |
Value of fidelity bond cover | 2011-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2011-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2011-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2011-12-31 | No |
Contributions received from participants | 2011-12-31 | $1,824,185 |
Participant contributions at end of year | 2011-12-31 | $343,316 |
Participant contributions at beginning of year | 2011-12-31 | $345,494 |
Income. Received or receivable in cash from other sources (including rollovers) | 2011-12-31 | $14,923 |
Administrative expenses (other) incurred | 2011-12-31 | $15,909 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Value of net income/loss | 2011-12-31 | $771,202 |
Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $15,216,616 |
Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $14,445,414 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2011-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2011-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2011-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2011-12-31 | $14,873,300 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2011-12-31 | $14,099,920 |
Interest on participant loans | 2011-12-31 | $17,745 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2011-12-31 | $-972,806 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2011-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2011-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2011-12-31 | No |
Contributions received in cash from employer | 2011-12-31 | $857,226 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2011-12-31 | $1,253,017 |
Did the plan have assets held for investment | 2011-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2011-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2011-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2011-12-31 | Disclaimer |
Accountancy firm name | 2011-12-31 | MAXWELL LOCKE & RITTER LLP |
Accountancy firm EIN | 2011-12-31 | 742900215 |
2010 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2010 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2010-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
Total income from all sources (including contributions) | 2010-12-31 | $4,082,269 |
Total loss/gain on sale of assets | 2010-12-31 | $0 |
Total of all expenses incurred | 2010-12-31 | $1,010,847 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2010-12-31 | $967,987 |
Expenses. Certain deemed distributions of participant loans | 2010-12-31 | $130 |
Value of total corrective distributions | 2010-12-31 | $28,873 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2010-12-31 | $2,751,850 |
Value of total assets at end of year | 2010-12-31 | $14,445,414 |
Value of total assets at beginning of year | 2010-12-31 | $11,373,992 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-12-31 | $13,857 |
Total interest from all sources | 2010-12-31 | $21,619 |
Total dividends received (eg from common stock, registered investment company shares) | 2010-12-31 | $190,130 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2010-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2010-12-31 | $190,130 |
Was this plan covered by a fidelity bond | 2010-12-31 | Yes |
Value of fidelity bond cover | 2010-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2010-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2010-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2010-12-31 | No |
Contributions received from participants | 2010-12-31 | $1,761,771 |
Participant contributions at end of year | 2010-12-31 | $345,494 |
Participant contributions at beginning of year | 2010-12-31 | $343,576 |
Income. Received or receivable in cash from other sources (including rollovers) | 2010-12-31 | $178,641 |
Administrative expenses (other) incurred | 2010-12-31 | $13,857 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Value of net income/loss | 2010-12-31 | $3,071,422 |
Value of net assets at end of year (total assets less liabilities) | 2010-12-31 | $14,445,414 |
Value of net assets at beginning of year (total assets less liabilities) | 2010-12-31 | $11,373,992 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2010-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2010-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2010-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2010-12-31 | $14,099,920 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2010-12-31 | $11,030,416 |
Interest on participant loans | 2010-12-31 | $21,619 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2010-12-31 | $1,118,670 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2010-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2010-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2010-12-31 | No |
Contributions received in cash from employer | 2010-12-31 | $811,438 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2010-12-31 | $967,987 |
Did the plan have assets held for investment | 2010-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2010-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2010-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2010-12-31 | Disclaimer |
Accountancy firm name | 2010-12-31 | MAXWELL LOCKE & RITTER LLP |
Accountancy firm EIN | 2010-12-31 | 742900215 |
2009 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2009 401k financial data |
---|
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2009-12-31 | $0 |